p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma

World Health Organization Classification of Tumours

Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

Kwak, E. L., Bang, Y.-J., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S.-H. I., Dezube, B. J., Jänne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,446

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

Shigematsu, H., Lin, L., Takahashi, T., Nomura, M., Suzuki, M., Wistuba, I. I., Fong, K. M., Lee, H., Toyooka, S., Shimizu, N., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji055 · Cited by 2,377

p63, a p53 Homolog at 3q27–29, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative Activities

Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dötsch, V., Andrews, N. C., Caput, D., & McKeon, F. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80275-0 · Cited by 2,085

Pathology and genetics of tumours of the lung , pleura, thymus and heart

Travis, W. D. (2004) · Cited by 1,955

Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

Johnson, D. H., Fehrenbacher, L., Novotny, W. F., Herbst, R. S., Nemunaitis, J. J., Jablons, D. M., Langer, C. J., DeVore, R. F., Gaudreault, J., Damico, L. A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.022 · Cited by 1,937

p63 Is Essential for the Proliferative Potential of Stem Cells in Stratified Epithelia

Senoo, M., Pinto, F., Crum, C. P., & McKeon, F. (2007) · Cell · doi:10.1016/j.cell.2007.02.045 · Cited by 881

Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

Weiss, J., Sos, M. L., Seidel, D., Peifer, M., Zander, T., Heuckmann, J. M., Ullrich, R. T., Menon, R., Maier, S., Soltermann, A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001451 · Cited by 821

p63 expression profiles in human normal and tumor tissues.

Como, C. J. D., Urist, M. J., Babayan, I., Drobnjak, M., Hedvat, C. V., Teruya‐Feldstein, J., Kamal, P., Hoos, A., & Cordon‐Cardo, C. (2002) · PubMed · Cited by 511

Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer

Hammerman, P. S., Sos, M. L., Ramos, A. H., Xu, C., Dutt, A., Zhou, W., Brace, L. E., Woods, B. A., Lin, W., Zhang, J., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-11-0005 · Cited by 482

AIS is an oncogene amplified in squamous cell carcinoma

Hibi, K., Trink, B., Patturajan, M., Westra, W. H., Caballero, O. L., Hill, D. E., Ratovitski, E. A., Jen, J., & Sidransky, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5462 · Cited by 463

Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens

Rekhtman, N., Ang, D. C., Sima, C. S., Travis, W. D., & Moreira, A. L. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.92 · Cited by 339

Significance of p63 amplification and overexpression in lung cancer development and prognosis.

Massion, P. P., Taflan, P. M., Rahman, S. M. J., Yildiz, P., Shyr, Y., Edgerton, M. E., Westfall, M. D., Roberts, J. R., Pietenpol, J. A., Carbone, D. P., et al. (2003) · PubMed · Cited by 320

Subclassification of Non-small Cell Lung Carcinomas Lacking Morphologic Differentiation on Biopsy Specimens: Utility of an Immunohistochemical Panel Containing TTF-1, Napsin A, p63, and CK5/6

Mukhopadhyay, S., & Katzenstein, A.-L. A. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182036d05 · Cited by 314

Differential expression of p63 isoforms in normal tissues and neoplastic cells

Nylander, K., Vojtesek, B., Nenutil, R., Lindgren, B., Roos, G., Zhanxiang, W., Sjöström, B., Dahlqvist, Å., & Coates, P. J. (2002) · The Journal of Pathology · doi:10.1002/path.1231 · Cited by 276

Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer

Scagliotti, G., Brodowicz, T., Shepherd, F. A., Zielinski, C., Vansteenkiste, J., Manegold, C., Simms, L., Fossella, F., Sugarman, K., & Belani, C. P. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f7c6d4 · Cited by 252

Subtyping of Undifferentiated Non-small Cell Carcinomas in Bronchial Biopsy Specimens

Loo, P. S., Thomas, S. C., Nicolson, M. C., Fyfe, M. N., & Kerr, K. M. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d40fac · Cited by 226

Accurate Classification of Non–Small Cell Lung Carcinoma Using a Novel MicroRNA-Based Approach

Bishop, J. A., Benjamin, H., Cholakh, H., Chajut, A., Clark, D. P., & Westra, W. H. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2638 · Cited by 223

Refining the Diagnosis and EGFR Status of Non-small Cell Lung Carcinoma in Biopsy and Cytologic Material, Using a Panel of Mucin Staining, TTF-1, Cytokeratin 5/6, and P63, and EGFR Mutation Analysis

Nicholson, A. G., Gonzalez, D., Shah, P., Pynegar, M. J., Deshmukh, M., Rice, A., & Popat, S. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181c6ed9b · Cited by 215

p63 in Epithelial Survival, Germ Cell Surveillance, and Neoplasia

Crum, C. P., & McKeon, F. D. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102117 · Cited by 215

Abnormal Re-epithelialization and Lung Remodeling in Idiopathic Pulmonary Fibrosis: The Role of ΔN-p63

Chilosi, M., Poletti, V., Murer, B., Lestani, M., Cancellieri, A., Montagna, L., Piccoli, P., Cangi, G., Semenzato, G., & Doglioni, C. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000032380.82232.67 · Cited by 212

Optimal Immunohistochemical Markers For Distinguishing Lung Adenocarcinomas From Squamous Cell Carcinomas in Small Tumor Samples

Terry, J., Leung, S., Laskin, J., Leslie, K. O., Gown, A. M., & Ionescu, D. N. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181f7dae3 · Cited by 198

The Diagnostic Value of TTF-1, CK 5/6, and p63 Immunostaining in Classification of Lung Carcinomas

Kargi, A., Gurel, D., & Tuna, B. (2007) · Applied Immunohistochemistry & Molecular Morphology · doi:10.1097/pai.0b013e31802fab75 · Cited by 179

Pathological Diagnosis and Classification of Lung Cancer in Small Biopsies and Cytology: Strategic Management of Tissue for Molecular Testing

Travis, W., & Rekhtman, N. (2011) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0031-1272866 · Cited by 168

Distinct Expression Profiles of p63 Variants during Urothelial Development and Bladder Cancer Progression

Karni-Schmidt, O., Castillo-Martín, M., HuaiShen, T., Gladoun, N., Domenech, J. M. D., Sänchez‐Carbayo, M., Li, Y., Lowe, S. W., Prives, C. L., & Cordon‐Cardo, C. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.061 · Cited by 145

Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine‐needle aspiration cytology: A retrospective study of 103 cases with surgical correlation

Righi, L., Graziano, P., Fornari, A., Rossi, G., Barbareschi, M., Cavazza, A., Pelosi, G., Scagliotti, G. V., & Papotti, M. G. (2011) · Cancer · doi:10.1002/cncr.25830 · Cited by 144

Dominant Negative p63 Isoform Expression in Head and Neck Squamous Cell Carcinoma

Sniezek, J. C., Matheny, K. E., Westfall, M. D., & Pietenpol, J. A. (2004) · The Laryngoscope · doi:10.1097/01.mlg.0000149437.35855.4b · Cited by 132

Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component

Yoshida, A., Tsuta, K., WATANABE, S.-I. I., Sekine, I., Fukayama, M., Tsuda, H., Furuta, K., & Shibata, T. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.09.013 · Cited by 118

Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung

Monica, V., Ceppi, P., Righi, L., Tavaglione, V., Volante, M., Pelosi, G., Scagliotti, G. V., & Papotti, M. G. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.30 · Cited by 100

Utility of 10 Immunohistochemical Markers Including Novel Markers (Desmocollin-3, Glypican 3, S100A2, S100A7, and Sox-2) for Differential Diagnosis of Squamous Cell Carcinoma from Adenocarcinoma of the Lung

Tsuta, K., Tanabe, Y., Yoshida, A., Takahashi, F., Maeshima, A. M., Asamura, H., & Tsuda, H. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318219ac78 · Cited by 99

Expression of p63 in Diffuse Large B-Cell Lymphoma

Hedvat, C. V., Teruya‐Feldstein, J., Puig, P., Capodieci, P., Dudas, M. E., Pica, N., Qin, J., Cordon‐Cardo, C., & Como, C. J. D. (2005) · Applied immunohistochemistry & molecular morphology · doi:10.1097/01.pai.0000142160.52670.ce · Cited by 56

Constitutive expression of ?N-p63? isoform in human thymus and thymic epithelial tumours

Chilosi, M., Zam�, A., Brighenti, A., Malpeli, G., Montagna, L., Piccoli, P., Pedron, S., Lestani, M., Inghirami, G., Scarpa, A., et al. (2003) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-003-0857-4 · Cited by 50

miR-205 Expression Levels in Nonsmall Cell Lung CancerDo Not Always Distinguish Adenocarcinomas From Squamous Cell Carcinomas

Vescovo, V. D., Cantaloni, C., Cucino, A., Girlando, S., Silvestri, M., Bragantini, E., Fasanella, S., Cuorvo, L. V., Palma, P., Rossi, G., et al. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182068171 · Cited by 49

The transactivating isoforms of p63 are overexpressed in high‐grade follicular lymphomas independent of the occurrence of p63 gene amplification

Pruneri, G., Fabris, S., Dell’Orto, P., Biasi, M. O., Valentini, S., Curto, B. D., Laszlò, D., Cattaneo, L., Fasani, R., Rossini, L., et al. (2005) · The Journal of Pathology · doi:10.1002/path.1787 · Cited by 45

Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas

Zamò, A., Malpeli, G., Scarpa, A., Doglioni, C., Chilosi, M., & Menestrina, F. (2005) · Modern Pathology · doi:10.1038/modpathol.3800440 · Cited by 27

The 2015 World Health Organization Classification of Lung Tumors

Travis, W. D., Brambilla, E., Nicholson, A. G., Yatabe, Y., Austin, J. H. M., Beasley, M. B., Chirieac, L. R., Dacic, S., Duhig, E., Flieder, D. B., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000630 · Cited by 4,520

Comprehensive genomic characterization of squamous cell lung cancers

The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994

Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification

Inamura, K. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00193 · Cited by 503

Diagnosis of Lung Cancer in Small Biopsies and Cytology: Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification

Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K., Yatabe, Y., Ishikawa, Y., Wistuba, I., Flieder, D. B., Franklin, W., et al. (2013) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2012-0263-ra · Cited by 414

Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

Yatabe, Y., Dacic, S., Borczuk, A. C., Warth, A., Russell, P. A., Lantuejoul, S., Beasley, M. B., Thunnissen, E., Pelosi, G., Rekhtman, N., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.12.005 · Cited by 365